What is ContextVision AB (publ) (CONTX.OL)?

ContextVision AB (publ) (CONTX.OL) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

ContextVision AB (publ) (CONTX.OL)

Stock analysis · OSL · Healthcare · Medical - Healthcare Information Services

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.18

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

ContextVision AB (publ) (CONTX.OL) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

May 6, 2026

EPS $0.01 vs est. $0.05

Missed by $0.04

Proprietary Signals

Signal snapshot temporarily unavailable.

About ContextVision AB (publ)

ContextVision AB (publ), a medical technology enterprise established in Stockholm, Sweden, in 1983, delivers sophisticated software solutions. The firm specializes in image analysis and artificial intelligence, supplying these advanced technologies to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. Their comprehensive product suite is designed to optimize image quality across various medical imaging modalities, including two-dimensional, three-dimensional, and four-dimensional ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key offerings include: Rivent: Provides superior image quality for a broad spectrum of ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. VolarView: An image enhancement software specifically developed for the burgeoning handheld ultrasound market. GOPiCE: A proprietary technology enabling real-time volumetric image enhancement. Altumira/Altumira Plus: A robust platform for digital radiography. An Orthopedic Package: Tailored for specialized orthopedic imaging needs. GOPView MRI2Plus: An advanced solution for MRI image improvement. INIFY Prostate Scr…